152 related articles for article (PubMed ID: 14501780)
41. Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle.
Li CG; Rand MJ
Clin Exp Pharmacol Physiol; 1989 Dec; 16(12):933-8. PubMed ID: 2558828
[TBL] [Abstract][Full Text] [Related]
42. [Mechanism of relaxation mediated by nitric oxide on human lower esophageal sphincter].
Wen SW; Liu JF; Gao LP; Tian ZQ; Wang QZ; Li BQ
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):31-4. PubMed ID: 16606532
[TBL] [Abstract][Full Text] [Related]
43. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
44. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase.
Faraci FM; Brian JE; Heistad DD
Am J Physiol; 1995 Nov; 269(5 Pt 2):H1522-7. PubMed ID: 7503244
[TBL] [Abstract][Full Text] [Related]
45. Endogenous nitric oxide synthase inhibitors in endothelial cells, endothelin-1 within the vessel wall, and intimal hyperplasia in perimenopausal human uterine arteries.
Beppu M; Obayashi S; Aso T; Goto M; Azuma H
J Cardiovasc Pharmacol; 2002 Feb; 39(2):192-200. PubMed ID: 11791004
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline.
Lee TJ; Sarwinski S; Ishine T; Lai CC; Chen FY
J Pharmacol Exp Ther; 1996 Feb; 276(2):353-8. PubMed ID: 8632296
[TBL] [Abstract][Full Text] [Related]
47. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects.
Cable DG; Celotto AC; Evora PR; Schaff HV
Med Sci Monit; 2009 Sep; 15(9):BR248-53. PubMed ID: 19721392
[TBL] [Abstract][Full Text] [Related]
48. Effects of some guanidino compounds on human cerebral arteries.
Segarra G; Medina P; Ballester RM; Lluch P; Aldasoro M; Vila JM; Lluch S; Pelligrino DA
Stroke; 1999 Oct; 30(10):2206-10; discussion 2210-11. PubMed ID: 10512930
[TBL] [Abstract][Full Text] [Related]
49. Nitric oxide relaxes rabbit corpus cavernosum smooth muscle via a potassium-conductive pathway.
Seftel AD; Viola KA; Kasner SE; Ganz MB
Biochem Biophys Res Commun; 1996 Feb; 219(2):382-7. PubMed ID: 8604996
[TBL] [Abstract][Full Text] [Related]
50. The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutrition.
Servillo L; Giovane A; Cautela D; Castaldo D; Balestrieri ML
Nitric Oxide; 2013 Apr; 30():43-8. PubMed ID: 23438481
[TBL] [Abstract][Full Text] [Related]
51. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
[TBL] [Abstract][Full Text] [Related]
52. Plasma concentrations of three methylated arginines, endogenous nitric oxide synthase inhibitors, in schizophrenic patients undergoing antipsychotic drug treatment.
Nonaka-Hashida S; Sekine M; Ozeki Y; Fujii K; Akiyama K; Shimoda K; Tsunoda M; Katane M; Saitoh Y; Miyamoto T; Homma H
Psychiatry Res; 2016 Apr; 238():203-210. PubMed ID: 27086234
[TBL] [Abstract][Full Text] [Related]
53. Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.
Ghasemi M; Sadeghipour H; Shafaroodi H; Nezami BG; Gholipour T; Hajrasouliha AR; Tavakoli S; Nobakht M; Moore KP; Mani AR; Dehpour AR
Br J Pharmacol; 2007 Jul; 151(5):591-601. PubMed ID: 17486141
[TBL] [Abstract][Full Text] [Related]
54. The effect of nitric oxide on acetylcholine release in the rabbit bladder.
Miyamoto Y; Yoshida M; Takahashi W; Inadome A; Yono M; Seshita H; Murakami S; Ueda S
Eur J Pharmacol; 2001 Sep; 428(1):59-67. PubMed ID: 11779038
[TBL] [Abstract][Full Text] [Related]
55. Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro.
Ramnarine SI; Khawaja AM; Barnes PJ; Rogers DF
Br J Pharmacol; 1996 Jun; 118(4):998-1002. PubMed ID: 8799574
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.
Brunini T; Moss M; Siqueira M; Meirelles L; Rozentul A; Mann G; Ellory J; Soares de Moura R; Mendes-Ribeiro A
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):738-40. PubMed ID: 15554917
[TBL] [Abstract][Full Text] [Related]
57. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro.
Belenky SN; Robbins RA; Rubinstein I
J Leukoc Biol; 1993 May; 53(5):498-503. PubMed ID: 7684763
[TBL] [Abstract][Full Text] [Related]
58. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function.
Cardounel AJ; Cui H; Samouilov A; Johnson W; Kearns P; Tsai AL; Berka V; Zweier JL
J Biol Chem; 2007 Jan; 282(2):879-87. PubMed ID: 17082183
[TBL] [Abstract][Full Text] [Related]
59. Involvement of nitric oxide in inhibitory innervation of urinary bladder of Atlantic cod, Gadus morhua.
Olsson C; Holmgren S
Am J Physiol; 1996 Jun; 270(6 Pt 2):R1380-5. PubMed ID: 8764307
[TBL] [Abstract][Full Text] [Related]
60. Attenuation of human chorionic gonadotropin release by nitric oxide in choriocarcinoma cell lines.
Myat-Thanda ; Hitsumoto Y; Saheki S; Kitagawa H; Yano J; Matsuura S
J Endocrinol; 1996 Aug; 150(2):243-53. PubMed ID: 8869591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
